CDTX - Cidara Therapeutics GAAP EPS of -$0.19 misses by $0.04 revenue of $10.22M misses by $0.35M
2023-03-23 07:53:26 ET
- Cidara Therapeutics press release ( NASDAQ: CDTX ): Q4 GAAP EPS of -$0.19 misses by $0.04 .
- Revenue of $10.22M (+41.9% Y/Y) misses by $0.35M .
- Cash and cash equivalents totaled $32.7 million as of December 31, 2022, compared with cash, cash equivalents and restricted cash of $62.3 million as of December 31, 2021.
For further details see:
Cidara Therapeutics GAAP EPS of -$0.19 misses by $0.04, revenue of $10.22M misses by $0.35M